Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report

被引：2896

作者：

Malfertheiner, P. ^{[1
]}

Megraud, F. ^{[2
]}

O'Morain, C. A. ^{[3
]}

Gisbert, J. P. ^{[4
,5
]}

Kuipers, E. J. ^{[6
]}

Axon, A. T. ^{[7
]}

Bazzoli, F. ^{[8
]}

Gasbarrini, A. ^{[9
]}

Atherton, J.

Graham, D. Y. ^{[10
]}

Hunt, R. ^{[11
,12
]}

Moayyedi, P. ^{[13
]}

Rokkas, T. ^{[14
]}

Rugge, M. ^{[15
]}

Selgrad, M.

Suerbaum, S. ^{[16
]}

Sugano, K. ^{[17
]}

El-Omar, E. M. ^{[18
]}

机构：

[1] Otto von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany

[2] Univ Bordeaux, Inserm U853, Bacteriol Lab, Bordeaux, France

[3] Trinity Coll Dublin, Fac Hlth Sci, Dublin, Ireland

[4] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IP, Dept Gastroenterol, Madrid, Spain

[5] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain

[6] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

[7] Gen Infirm Leeds, Leeds, W Yorkshire, England

[8] Univ Bologna, Internal Med & Gastroenterol, Bologna, Italy

[9] Gastroenterol & Liver Unit, Internal Med, Rome, Italy

[10] Michael E DeBakey VA Med Ctr, Dept Med 111D, Houston, TX USA

[11] McMaster Univ, Dept Med, Hamilton, ON, Canada

[12] Hillcroft, Beaconsfield, Bucks, England

[13] McMaster Univ, Dept Gastroenterol, Hamilton, ON, Canada

[14] Henry Dunant Hosp, Dept Gastroenterol, Athens, Greece

[15] Univ Padua, Dept Diagnost Sci, Padua, Italy

[16] Hannover Med Sch, Inst Med Mikrobiol, Hannover, Germany

[17] Jichi Med Sch, Dept Med, Shimotsuke, Tochigi, Japan

[18] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia

来源：

GUT | 2017年 / 66卷 / 01期

关键词：

PROTON-PUMP INHIBITOR; CONTAINING QUADRUPLE THERAPY; C-13-UREA BREATH TEST; GASTRIC-CANCER RISK; CONTAINING TRIPLE THERAPY; 3RD-LINE RESCUE THERAPY; PEPTIC-ULCER DISEASE; LOW-DOSE ASPIRIN; SACCHAROMYCES-BOULARDII SUPPLEMENTATION; GASTROESOPHAGEAL-REFLUX DISEASE;

D O I：

10.1136/gutjnl-2016-312288

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios.

引用

页码：6 / 30

页数：25

共 414 条

[51]

Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study [J].